Finance Home - My Yahoo - Yahoo! - Help

Saturday, December 5, 2009, 10:51PM ET - U.S. Markets Closed. Dow  0.22% Nasdaq  0.98%

Oncolytics Biotech, Inc. (ONCY)

On Dec 4: 2.89   0.00 (0.00%)

MORE ON ONCY

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Headlines Get Headlines for:
Change Display [ hide $$  edit ] Wed, Dec 2, 2009 • Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option PR Newswire (Wed, Dec 2) Mon, Nov 23, 2009 • Oncolytics Biotech(R) Inc. Closes US$12.75 Million Unit Offering PR Newswire (Mon, Nov 23) Wed, Nov 18, 2009 • Oncolytics Biotech(R) Inc. Announces Terms of Unit Offering PR Newswire (Wed, Nov 18) • Poniard, Netlist: Early Volume Plays at TheStreet.com (Wed, Nov 18) Tue, Nov 17, 2009 • Oncolytics Biotech(R) Inc. Announces Unit Offering PR Newswire (Tue, Nov 17) • Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase I/II Trial Results in Advanced Solid Cancers with a Focus on the Head and Neck at the AACR-NCI-EORTC Meeting PR Newswire (Tue, Nov 17) Mon, Nov 16, 2009 • Oncolytics Biotech(R) Inc. Collaborators to Present Updated Phase I/II Trial Results in Advanced Solid Cancers with a Focus on the Head and Neck at the AACR-NCI-EORTC Meeting PR Newswire (Mon, Nov 16) Sun, Nov 8, 2009 • New Star Analyst Rankings for Oncolytics Biotech, Inc. StarMine (Sun, Nov 8) Fri, Nov 6, 2009 • Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting PR Newswire (Fri, Nov 6) Thu, Nov 5, 2009 • Oncolytics Biotech(R) Inc. Announces 2009 Third Quarter Results PR Newswire (Thu, Nov 5) Tue, Nov 3, 2009 • Oncolytics Biotech(R) Inc. Announces Results of Second Warrant Expiry Date Acceleration Program PR Newswire (Tue, Nov 3) Mon, Nov 2, 2009 • Media Advisory - Oncolytics Biotech(R) Inc. to Present at BIO-Europe 2009 PR Newswire (Mon, Nov 2) Fri, Oct 30, 2009 • Oncolytics Biotech(R) Inc. Collaborators to Present Phase II Sarcoma Trial Results at CTOS Annual Meeting PR Newswire (Fri, Oct 30) Tue, Oct 27, 2009 • Oncolytics(R) Biotech Inc. Announces Issuance of 33rd U.S. Patent PR Newswire (Tue, Oct 27) Mon, Oct 26, 2009 • Oncolytics Biotech(R) Inc. Announces Results of First Warrant Expiry Date Acceleration Program PR Newswire (Mon, Oct 26) Fri, Oct 23, 2009 • Media Advisory - Oncolytics Biotech Inc. to Present at BIO Investor Forum 2009 PR Newswire (Fri, Oct 23) Tue, Oct 20, 2009 • Oncolytics Biotech(R) Inc. Announces Investment in Private Biotechnology Company PR Newswire (Tue, Oct 20) Wed, Oct 7, 2009 • Media Advisory - Oncolytics Biotech(R) Inc. to Present at BioPartnering Europe PR Newswire (Wed, Oct 7) • StockPreacher.com Issues Trading Overview for Oncolytics Biotech Inc. GlobeNewswire (Wed, Oct 7) Fri, Oct 2, 2009 • Oncolytics Biotech(R) Inc. Accelerates Warrant Expiry Date PR Newswire (Fri, Oct 2) Older Headlines - Download Recent Headlines View headlines from: Fri, Oct 2, 2009Fri, Sep 25, 2009Fri, Sep 18, 2009Fri, Sep 11, 2009Fri, Sep 4, 2009Fri, Aug 28, 2009Fri, Aug 21, 2009Fri, Aug 14, 2009Fri, Aug 7, 2009Fri, Jul 31, 2009 Add ONCY News to My Yahoo!:
Add to Portfolio     Set Alert     Email to a Friend Get Headlines for Another Symbol: Symbol Lookup • Stocks In Play • Story Stocks • Full Coverage